GeneReach Biotechnology Past Performance

How has GeneReach Biotechnology performed over the past 5 years?

Past Performance Score

4/6

Past Performance Score 4/6

  • Quality Earnings

  • Growing Profit Margin

  • Earnings Trend

  • Accelerating Growth

  • Earnings vs Industry

  • High ROE


60.2%

Historical annual earnings growth

Earnings and Revenue History

Quality Earnings: 4171 has high quality earnings.

Growing Profit Margin: 4171's current net profit margins (38.1%) are higher than last year (37.6%).


Past Earnings Growth Analysis

Earnings Trend: 4171 has become profitable over the past 5 years, growing earnings by 60.2% per year.

Accelerating Growth: 4171's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 4171 had negative earnings growth (-16.4%) over the past year, making it difficult to compare to the Medical Equipment industry average (28.2%).


Return on Equity

High ROE: 4171's Return on Equity (28.4%) is considered high.


Discover strong past performing companies